- ... of the cases in the 483 ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH ... T-cell antibody (0-0-5%). No anti-graft-versus-host disease prophylaxis was given after transplantation. Rapid engraftment was ...
- ... and the risk of related-donor transfusion-associated graft-versus-host disease. McMilin KD, et al. Transfus Med Rev 1993 ... and the risk of related-donor transfusion-associated graft-versus-host disease. McMilin KD, et al. Transfus Med Rev 1993 ...
- NLM Digital Collections - Analysis of supply, distribution, demand, and access issues associated with immune globulin ...Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, 2007... pneumonia of infectious or idiopathic causes, and acute graft-versus-host disease after transplantation Source: Orange et al., 2006 An ... reduce the incidences of infection and to prevent graft versus host disease, in which the new donor cells attack the ...
- ... A multivariate approach for assessing severity of acute graft-versus-host disease in bone marrow transplantation. Parrish RS, et al. ... A multivariate approach for assessing severity of acute graft-versus-host disease in bone marrow transplantation. Parrish RS, et al. ...
- ... marrow transplantation: effect on infectious complications, fever and graft versus host disease. Skinh0j P, et al. Scand J Infect Dis ... marrow transplantation: effect on infectious complications, fever and graft versus host disease. Skinh0j P, et al. Scand J Infect Dis ...
- NLM Digital Collections - Manufacture of blood components using a pathogen reduction device in blood establishments : ...Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, November 2021... platelets to prevent the risk of transfusion- associated graft versus host disease (TA-GVHD)? Yes. As described in the FDA- ... to gamma irradiation for prevention of transfusion-associated graft versus host disease (TA-GVHD). 2 Contains Nonbinding Recommendations 5. Can ...
- NLM Digital Collections - Beikoku Kokuritsu Igaku Toshokan bunruihō : igaku oyobi kanren bun'ya ni okeru tosho haikahōPublication: Tōkyō : Nihon Igaku Toshokan Kyōkai, 1996... see Leukemia Viruses, Murine Graft Rejection WO 680 Graft-Versus-Host Disease see Graft vs Host Disease Graft vs Host Disease WD 300 Transplantation complication ...
- NLM Digital Collections - National Library of Medicine classification : a scheme for the shelf arrangement of library ...Publication: Bethesda, Md. : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine ; Washington, DC : For sale by the Supt. of Docs., U.S. G.P.O., 1999... Occlusion, Vascular WG 170 Graft Rejection WO 680 Graft-Versus-Host Disease see Graft vs Host Disease Graft vs Host Disease WD 300 Transplantation complication ...
- NLM Digital Collections - Chimeric antigen receptor T-cell therapy for B-cell cancers : effectiveness and value : final ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 23, 2018... Grade 2 to 4 acute or extensive chronic graft-versus-host disease (GVHD) Active or latent hepatitis B or active ... relapse disease ≥ 25% blasts in bone marrow Active graft versus Performance status ≥50% host disease SCT in past 3 months Hijiya 201122 Clofarabine + ...
- ... DiGeorge syn- drome, Wiskott-Aldrich syndrome, ataxia-telangiectasia, graft versus host disease, neu- tropenia, neutrophil function abnormality, agammaglobulinemia, or hypogammaglobuline- ...
282 results